Company Overview - 加和国际控股有限公司 is a contract manufacturer based in Singapore, specializing in the production and sale of disposable medical devices and injection-molded plastic components, as well as providing mold-making services [3] - The company was established in 1981 and has become a reliable contract manufacturer for major international healthcare and medical device companies [3] - The revenue streams of the company include manufacturing and selling disposable medical device components and providing mold-making services [3] Financial Performance - As of December 31, 2024, 加和国际控股 reported total revenue of 55.6565 million yuan, representing a year-on-year growth of 14.33% [2] - The company recorded a net profit attributable to shareholders of -14.0006 million yuan, which is a year-on-year increase of 61% [2] - The gross profit margin stands at 2.18%, while the debt-to-asset ratio is 75.71% [2] Market Position and Valuation - Over the past month, 加和国际控股 has experienced a cumulative decline of 10.34%, and a year-to-date decline of 26.55%, underperforming the Hang Seng Index, which has increased by 18.2% [2] - The company's price-to-earnings (P/E) ratio is -7.04, ranking 83rd in the industry, while the average P/E ratio for the healthcare equipment and services industry is -21.64 [2] - Other companies in the same sector have P/E ratios such as 巨星医疗控股 at 0.33, 京玖康疗 at 0.38, 永胜医疗 at 4.25, 环球医疗 at 4.64, and 瑞慈医疗 at 5.2 [2]
加和国际控股（08513.HK）6月19日收盘上涨6.15%，成交3.02万港元